Literature DB >> 10559338

Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

P J Lewis1, L A Babiuk.   

Abstract

The potential for DNA vaccines encoding mutated versions of the same antigen to modulate immune responses in C3H/HeN mice was investigated. We created expression plasmids that encoded several versions of glycoprotein D (gD) from bovine herpesvirus 1, including authentic membrane-anchored glycoprotein (pSLRSV.AgD), a secreted glycoprotein (pSLRSV.SgD), and an intracellular protein (pSLRSV.CgD). Immunization of an inbred strain of mice with these plasmids resulted in highly efficacious and long-lasting humoral and cell-mediated immunity. We also demonstrated that the cell compartment in which plasmid-encoded gD was expressed caused a deviation in the serum immunoglobulin (Ig) isotype profile as well as the predominant cytokines secreted from the draining lymph node. Immunization of C3H/HeN mice with DNA vaccines encoding cell-associated forms of gD resulted in a predominance of serum IgG2a and gamma interferon-secreting cells within the spleens and draining lymph nodes. In contrast, mice immunized with a secreted form of this same antigen displayed immune responses characterized by greater levels of interleukin 4 in the draining lymph node and IgG1 as the predominant serum isotype. We also showed evidence of compartmentalization of distinct immune responses within different lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559338      PMCID: PMC113075     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Cytokines and infectious diseases.

Authors:  M Fresno; M Kopf; L Rivas
Journal:  Immunol Today       Date:  1997-02

Review 2.  Vaccine strategies: selective elicitation of cellular or humoral immunity?

Authors:  G M Shearer; M Clerici
Journal:  Trends Biotechnol       Date:  1997-03       Impact factor: 19.536

Review 3.  The function of costimulatory molecules and the development of IL-4-producing T cells.

Authors:  W C Gause; M J Halvorson; P Lu; R Greenwald; P Linsley; J F Urban; F D Finkelman
Journal:  Immunol Today       Date:  1997-03

4.  Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA.

Authors:  H L Davis; C L Millan; S C Watkins
Journal:  Gene Ther       Date:  1997-03       Impact factor: 5.250

5.  Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1.

Authors:  J J Schlesinger; M W Brandriss; C B Cropp; T P Monath
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

6.  Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins.

Authors:  L A Babiuk; J L'Italien; S van Drunen Littel-van den Hurk; T Zamb; J P Lawman; G Hughes; G A Gifford
Journal:  Virology       Date:  1987-07       Impact factor: 3.616

7.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

8.  Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA.

Authors:  G J Cox; T J Zamb; L A Babiuk
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro.

Authors:  D L Lodmell; J J Esposito; L C Ewalt
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo.

Authors:  X Yang; R S Gieni; T R Mosmann; K T HayGlass
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  9 in total

1.  Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B.

Authors:  Hyun-Jeong Ko; Sung-Youl Ko; Yeon-Jeong Kim; Eun-Gae Lee; Sang-Nae Cho; Chang-Yuil Kang
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.

Authors:  Hong-Duck Kim; Kazuki Tahara; J Adam Maxwell; Robert Lalonde; Tatsuya Fukuiwa; Kohtaro Fujihashi; Kent R Van Kampen; Fan-Kun Kong; De-chu C Tang; Ken-ichiro Fukuchi
Journal:  J Gene Med       Date:  2007-02       Impact factor: 4.565

3.  Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.

Authors:  J T Qiu; B Liu; C Tian; G N Pavlakis; X F Yu
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

4.  Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization.

Authors:  Jin-Won Youn; Su-Hyung Park; Jae Ho Cho; Young Chul Sung
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

5.  Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles.

Authors:  D Marsac; D Loirat; C Petit; O Schwartz; M-L Michel
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.

Authors:  Gaetano Donofrio; Valentina Franceschi; Antonio Capocefalo; Simone Taddei; Chiara Sartori; Sabrina Bonomini; Sandro Cavirani; Clotilde S Cabassi; Cesidio F Flammini
Journal:  Clin Vaccine Immunol       Date:  2009-09-30

7.  Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors.

Authors:  Andrea Maria Blanc; Mabel Beatriz Berois; Lorena Magalí Tomé; Alberto L Epstein; Juan Ramón Arbiza
Journal:  J Vet Sci       Date:  2012-03       Impact factor: 1.672

8.  Enhanced induction of SARS-CoV nucleocapsid protein-specific immune response using DNA vaccination followed by adenovirus boosting in BALB/c mice.

Authors:  Ma Chunling; Yao Kun; Xu Jian; Qin Jian; Sun Hua; Zhu Minsheng
Journal:  Intervirology       Date:  2006-06-29       Impact factor: 1.763

Review 9.  Viral Vector Vaccines against Bluetongue Virus.

Authors:  Luis Jiménez-Cabello; Sergio Utrilla-Trigo; Eva Calvo-Pinilla; Sandra Moreno; Aitor Nogales; Javier Ortego; Alejandro Marín-López
Journal:  Microorganisms       Date:  2020-12-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.